BDBM50043571 1-[1-(5-Methyl-4H-[1,2,4]triazol-3-ylmethyl)-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3-m-tolyl-urea::CHEMBL136975

SMILES Cc1nnc(CN2c3ccccc3C(=NC(NC(=O)Nc3cccc(C)c3)C2=O)c2ccccc2)[nH]1

InChI Key InChIKey=MTWTWSXDRMUYIH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50043571   

TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50043571(1-[1-(5-Methyl-4H-[1,2,4]triazol-3-ylmethyl)-2-oxo...)
Affinity DataIC50:  9.70nMAssay Description:Inhibition of binding of [125I]-CCK-8 to the cholecystokinin type B receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(RAT)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50043571(1-[1-(5-Methyl-4H-[1,2,4]triazol-3-ylmethyl)-2-oxo...)
Affinity DataIC50:  566nMAssay Description:Inhibition of binding of [125I]CCK-8 to cholecystokinin type A receptor in rat pancreatic tissueMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed